-+ 0.00%
-+ 0.00%
-+ 0.00%

Outlook Therapeutics prices 16,129,033-share registered direct offering at USD 0.31

PUBT·04/22/2026 12:36:12
Listen to the news
Outlook Therapeutics prices 16,129,033-share registered direct offering at USD 0.31
  • Outlook Therapeutics priced a USD 5 million registered direct offering at USD 0.31 per share.
  • Deal covers 16,129,033 common shares or pre-funded warrants in lieu of shares.
  • Concurrent private placement includes unregistered warrants for up to 16,129,033 shares at USD 0.31 exercise price.
  • Closing expected April 23, 2026.
  • Net proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outlook Therapeutics Inc. published the original content used to generate this news brief on April 22, 2026, and is solely responsible for the information contained therein.